Literature DB >> 7151327

Properdin deficiency in a family with fulminant meningococcal infections.

A G Sjöholm, J H Braconier, C Söderström.   

Abstract

Three males in a large family showed a selective deficiency of properdin (P). One of the P deficient individuals died from a fulminant infection with Neisseria meningitidis group C. The family history revealed three previous cases of similar infections with a fatal outcome. The deficiency did not appear to be associated with repeated bacterial infections. The pattern of inheritance suggested an X-linked mode of transmittance. However, heterozygous carriers were not clearly distinguished in the family. P deficient serum supported immune haemolysis in a normal fashion. Alternative pathway functions, such as the activation of C3 by inulin or zymosan, lysis of guinea-pig erythrocytes in agarose gel and opsonization of endotoxin coated oil particles, were grossly impaired in P deficient serum while efficient C3 activation was produced by addition of cobra venom factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7151327      PMCID: PMC1536695     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Homozygous deficiency of C3 in a patient with repeated infections.

Authors:  C A Alper; H R Colten; F S Rosen; A R Rabson; G M Macnab; J S Gear
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

2.  Crossed immunoelectrophoresis and electroimmunoassay of IgM.

Authors:  A O Grubb
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Quantitation of immunoglobulin G by electrophoresis in agarose gel containing antibodies.

Authors:  A Grubb
Journal:  Scand J Clin Lab Invest       Date:  1970-11       Impact factor: 1.713

4.  Alternative pathway of complement: nonenzymatic, reversible transition of precursor to active properdin.

Authors:  O Götze; R G Medicus; H J Müller-Eberhard
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

6.  Complement components in normal serum and plasma quantitated by electroimmunoassay.

Authors:  A G Sjöholm
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

7.  Granulocyte function in chronic granulocytic leukemia. II. Bactericidal capacity, phagocytic rate, oxygen consumption, and granule protein composition in isolated granulocytes.

Authors:  T Olofsson; H Odeberg; I Olsson
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

8.  A second case of human C3b inhibitor (KAF) deficiency.

Authors:  R A Thompson; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

9.  Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.

Authors:  T P Stossel; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1973-03-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  46 in total

Review 1.  Properdin deficiency and meningococcal disease--identifying those most at risk.

Authors:  S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Sarika Agarwal; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 3.  Pathophysiology of meningococcal meningitis and septicaemia.

Authors:  N Pathan; S N Faust; M Levin
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

4.  Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.

Authors:  Viviana P Ferreira; Claudio Cortes; Michael K Pangburn
Journal:  Immunobiology       Date:  2010-02-12       Impact factor: 3.144

5.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 6.  Common Genetic Variants in the Complement System and their Potential Link with Disease Susceptibility and Outcome of Invasive Bacterial Infection.

Authors:  Bryan van den Broek; Michiel van der Flier; Ronald de Groot; Marien I de Jonge; Jeroen D Langereis
Journal:  J Innate Immun       Date:  2019-07-03       Impact factor: 7.349

7.  Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.

Authors:  G A Jarvis; N A Vedros
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

Review 8.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

Review 9.  Vaccination against meningococcus in complement-deficient individuals.

Authors:  B P Morgan; A Orren
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.

Authors:  G N Fredrikson; B Gullstrand; J Westberg; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.